Skip to content

News Category: Health & Medical

TargEDys and SymbioPharm enter an exclusive partnership to launch SymbioLife(R) Satylia(R) in Germany

By asianet

TargEDys and SymbioPharm signed an exclusive marketing and distribution agreement for the launch of SymbioLife(R) Satylia(R) in Germany. The novel dietary supplement based on the next-generation probiotic Hafnia alvei HA4597 will be available from January 2023. SymbioLife(R) Satylia(R) is a precision probiotic with a characterized mechanism of action at molecular level: it increases satiety thanks … Continued

Probiotic strain SNZ 1969(R) helps manage IBS-D & IBS-C symptoms effectively, latest clinical study shows

By asianet

Latest study shows Sanzyme Biologics’s Bacillus coagulans SNZ 1969(R)(Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms. This study is unique as it covers both the IBS-Diarrhea and IBS-Constipation groups with larger … Continued

COLOTECT – Non-invasive Colorectal Cancer Screening Test has been launched in Southeast Asia

By asianet

COLOTECT is a non-invasive colorectal cancer (CRC) self-sampling test that can detect the methylation status of exfoliated cell genes in the intestine, help screen for colorectal cancer and precancerous lesions risk, and detect bowel cancer risk even in the absence of active bleeding lesions, according to BkkGI. Colorectal cancer is the third most common cancer … Continued

CHUV, CERN and THERYQ join forces for a world first in cancer radiotherapy

By asianet

The Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland, the European Laboratory for Particle Physics (CERN) and THERYQ (ALCEN Group) have signed an agreement for the world-first development of a revolutionary FLASH radiotherapy device that will use very high energy electron (VHEE) radiation to treat cancers resistant to conventional treatments. The device, based on CERN … Continued

The 13th China (Taizhou) International Medical Expo successfully held

By asianet

From November 19 to 21, the 13th China (Taizhou) International Medical Expo was held in China Medical City (CMS). Themed “Healthy China Strategy Leading the Construction of Demonstration Zones”, this year’s expo held 23 special events including the CMS Policy Releasing and Project Signing Ceremony, and the 9th China (Taizhou) International Big Health Industry Talent … Continued

Jiangsu Traditional Chinese Medicine International Exchange Conference kicked off in Nanjing

By asianet

On November 21st, the “Jiangsu Traditional Chinese Medicine International Exchange Conference” jointly sponsored by the Foreign Affairs Office of Jiangsu Provincial People’s Government and Jiangsu Health Commission kicked off in Nanjing. The theme of the conference is “Let the World Know Jiangsu Traditional Chinese Medicine”, according to the organizing committee. Hu Gang, Vice-Chairman of the … Continued

Interplex Announces Stackable Multi-Row Board-to-Board Connector Products That Achieve Unprecedented Flexibility

By asianet

– Automotive-grade product offers a reliable, repeatable and versatile solution that can be scaled up in line with specific customer requirements Interplex [https://interplex.com/e-mobility/?utm_source=press_release&utm_campaign=e_mobility&utm_content=multi-row_BTB_press_release] a world leader in designing and manufacturing interconnect and mechanical products, is successfully addressing the growing market demand for high-density interconnects in challenging application scenarios. The company has just released its Multi-Row … Continued

Stephen Hermitage joins Sai Life Sciences as VP, CMC

By asianet

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organisation (CRO-CDMO)(https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=stephen-h-joins-slsc), today announced the joining of Stephen Hermitage (Steve) as Vice President, CMC. In this role Steve will join the global R&D leadership team at Sai Life Sciences, where he will add further deep scientific, process development and drug development experience to the … Continued

APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival

By asianet

RELIEF THERAPEUTICS Holding SA (SIX: RLF) (OTCQB: RLFTF) (RLFTD) (“Relief”), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent protected products in selected specialty, rare and ultra-rare disease areas on a global basis, today announced that its wholly owned subsidiary APR Applied Pharma Research SA (“APR”) has been nominated as a finalist in … Continued

Cambrex to Acquire Snapdragon Chemistry,  a Leader in Continuous Flow API Development Services

By asianet

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has entered into a definitive agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma … Continued